Literature DB >> 19816715

Final height of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome.

Teresinha Lermen Donatti1, Vera Hermina Koch.   

Abstract

The aim of this study was to evaluate the final stature of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome (INS) and the influence of disease-related issues on the achievement of their target heights. We analyzed 60 (41 male) patients and/or their records, with a minimum age of 19 years or at a Tanner's pubertal stage 4 for boys or status postmenarche for girls, and normal glomerular filtration rate. Mean age at first and last consultation was 5.3+/-2.4 years and 20.5+/-3.1 years, respectively. Mean follow-up period was 15.10 years. Mean cumulative dose of prednisone was 1254+/-831.40 mg/kg. Mean initial and final height Z scores (HtZ) were, respectively, -0.60+/-1.0 and -0.64+/-0.92 (p=0.72). The final HtZ showed a significant correlation only with the initial HtZ and the target HtZ (THZ). Six patients achieved a final HtZ below -2, which in male patients correlated strongly to the initial HtZ and THZ. A strong correlation was demonstrated between final HtZ, initial HtZ, and THZ. INS-related issues did not prevent the final stature to reach the predicted target height.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816715     DOI: 10.1007/s00467-009-1301-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Glucocorticoid therapy in children. Effect on somatomedin secretion.

Authors:  M J Elders; B S Wingfield; M L McNatt; J S Clarke; E R Hughes
Journal:  Am J Dis Child       Date:  1975-12

2.  Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.

Authors:  C N Lam; G C Arneil
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

3.  Standards for children's height at ages 2-9 years allowing for heights of parents.

Authors:  J M Tanner; H Goldstein; R H Whitehouse
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

4.  Adrenal function, growth, and insulin in patients treated with corticoids on alternate days.

Authors:  A Sadeghi-Nejad; B Senior
Journal:  Pediatrics       Date:  1969-02       Impact factor: 7.124

5.  Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate.

Authors:  J Baron; K O Klein; M J Colli; J A Yanovski; J A Novosad; J D Bacher; G B Cutler
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

6.  Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment.

Authors:  Mario Malerba; Simonetta Bossoni; Alessandro Radaeli; Erica Mori; Stefania Bonadonna; Andrea Giustina; Claudio Tantucci
Journal:  Chest       Date:  2005-02       Impact factor: 9.410

7.  Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids.

Authors:  R M Señarís; F Lago; R Coya; J Pineda; C Diéguez
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

Review 8.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

9.  Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone.

Authors:  M T Saha; P Laippala; H L Lenko
Journal:  Acta Paediatr       Date:  1998-05       Impact factor: 2.299

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  3 in total

1.  Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.

Authors:  Nynke Teeninga; Joana E Kist-van Holthe; Nienske van Rijswijk; Nienke I de Mos; Wim C J Hop; Jack F M Wetzels; Albert J van der Heijden; Jeroen Nauta
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

2.  Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?

Authors:  Nilüfer Göknar; Hazel Webb; Aoife Waters; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2021-11-12       Impact factor: 3.651

3.  Effect of prednisolone on linear growth in children with nephrotic syndrome.

Authors:  Ehsan Valavi; Majid Aminzadeh; Parisa Amouri; Afshin Rezazadeh; Maedeh Beladi-Mousavi
Journal:  J Pediatr (Rio J)       Date:  2018-09-18       Impact factor: 2.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.